• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈症发病机制中的遗传和环境因素。

Genetic and environmental factors in the pathogenesis of Huntington's disease.

作者信息

van Dellen Anton, Hannan Anthony J

机构信息

University Laboratory of Physiology, University of Oxford, Parks Road, OX1 3PT, Oxford, UK.

出版信息

Neurogenetics. 2004 Feb;5(1):9-17. doi: 10.1007/s10048-003-0169-5. Epub 2004 Jan 24.

DOI:10.1007/s10048-003-0169-5
PMID:14745585
Abstract

Huntington's disease is a fatal inherited disorder in which there is progressive neurodegeneration in specific brain areas, mainly the striatum and cerebral cortex, producing motor, cognitive, and psychiatric symptoms. The trinucleotide repeat mutation involved is common to many other brain diseases, which may therefore involve similar mechanisms of pathogenesis. We are beginning to understand how a CAG trinucleotide repeat expansion in the disease gene, encoding an expanded polyglutamine tract, induces neuronal dysfunction and symptomatology in Huntington's disease. Recent evidence that environmental factors modify the onset and progression of neurodegeneration has shed new light on Huntington's disease and other devastating brain diseases. This review focuses on genetic mediators, environmental modulators, and associated gene-environment interactions in the pathogenesis of Huntington's disease.

摘要

亨廷顿舞蹈症是一种致命的遗传性疾病,特定脑区(主要是纹状体和大脑皮层)会出现进行性神经退行性变,从而产生运动、认知和精神症状。所涉及的三核苷酸重复突变在许多其他脑部疾病中也很常见,因此这些疾病可能涉及相似的发病机制。我们开始了解疾病基因中的CAG三核苷酸重复扩增如何导致编码的多聚谷氨酰胺序列延长,进而在亨廷顿舞蹈症中诱发神经元功能障碍和症状表现。最近有证据表明环境因素会影响神经退行性变的发病和进展,这为亨廷顿舞蹈症及其他毁灭性脑部疾病带来了新的认识。本综述聚焦于亨廷顿舞蹈症发病机制中的遗传介质、环境调节因子以及相关的基因 - 环境相互作用。

相似文献

1
Genetic and environmental factors in the pathogenesis of Huntington's disease.亨廷顿舞蹈症发病机制中的遗传和环境因素。
Neurogenetics. 2004 Feb;5(1):9-17. doi: 10.1007/s10048-003-0169-5. Epub 2004 Jan 24.
2
Huntington's disease: which drugs might help patients?亨廷顿舞蹈症:哪些药物可能对患者有帮助?
IDrugs. 2004 Apr;7(4):351-8.
3
Gene-environment interactions, neuronal dysfunction and pathological plasticity in Huntington's disease.亨廷顿舞蹈病中的基因-环境相互作用、神经元功能障碍及病理性可塑性
Clin Exp Pharmacol Physiol. 2005 Dec;32(12):1007-19. doi: 10.1111/j.1440-1681.2005.04313.x.
4
Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington's disease.
Acta Biochim Pol. 2004;51(2):415-30.
5
Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease.突触蛋白失调、树突棘异常以及突触的病理性重塑作为亨廷顿病中经验依赖性认知和精神症状的中介物。
Neuroscience. 2013 Oct 22;251:66-74. doi: 10.1016/j.neuroscience.2012.05.043. Epub 2012 May 24.
6
Huntington's disease like-2: review and update.亨廷顿舞蹈症样2型:综述与更新
Acta Neurol Taiwan. 2005 Mar;14(1):1-8.
7
Selective neurodegeneration, neuropathology and symptom profiles in Huntington's disease.亨廷顿病的选择性神经退行性变、神经病理学和症状特征。
Adv Exp Med Biol. 2012;769:141-52. doi: 10.1007/978-1-4614-5434-2_9.
8
Huntington's Disease: Pathogenic Mechanisms and Therapeutic Targets.亨廷顿舞蹈症:致病机制与治疗靶点
Adv Neurobiol. 2017;15:93-128. doi: 10.1007/978-3-319-57193-5_4.
9
The therapeutic potential of G-protein coupled receptors in Huntington's disease.G 蛋白偶联受体在亨廷顿病中的治疗潜力。
Pharmacol Ther. 2010 Nov;128(2):305-23. doi: 10.1016/j.pharmthera.2010.07.008. Epub 2010 Aug 11.
10
Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease.在亨廷顿舞蹈病小鼠模型中,半胱天冬酶-1的抑制作用减缓了疾病进展。
Nature. 1999 May 20;399(6733):263-7. doi: 10.1038/20446.

引用本文的文献

1
Cognitive engagement may slow clinical progression and brain atrophy in Huntington's disease.认知参与可能会减缓亨廷顿病的临床进展和脑萎缩。
Sci Rep. 2024 Dec 4;14(1):30156. doi: 10.1038/s41598-024-76680-8.
2
Defective Mitochondrial Dynamics and Protein Degradation Pathways Underlie Cadmium-Induced Neurotoxicity and Cell Death in Huntington's Disease Striatal Cells.镉诱导亨廷顿病纹状体细胞神经毒性和细胞死亡的缺陷线粒体动力学和蛋白降解途径。
Int J Mol Sci. 2023 Apr 13;24(8):7178. doi: 10.3390/ijms24087178.
3
Cerebellar Predominant Increase in mRNA Expression Levels of Sirt1 and Sirt3 Isoforms in a Transgenic Mouse Model of Huntington's Disease.

本文引用的文献

1
Transcriptional abnormalities in Huntington disease.亨廷顿舞蹈症中的转录异常。
Trends Genet. 2003 May;19(5):233-8. doi: 10.1016/S0168-9525(03)00074-X.
2
Overexpression of heat shock protein 70 in R6/2 Huntington's disease mice has only modest effects on disease progression.热休克蛋白70在R6/2亨廷顿舞蹈病小鼠中的过表达对疾病进展仅有适度影响。
Brain Res. 2003 Apr 25;970(1-2):47-57. doi: 10.1016/s0006-8993(02)04275-0.
3
Apoptosis in Huntington's disease.亨廷顿舞蹈病中的细胞凋亡
亨廷顿病转基因小鼠模型中小脑 Sirt1 和 Sirt3 同工型的 mRNA 表达水平明显增加。
Neurochem Res. 2020 Sep;45(9):2072-2081. doi: 10.1007/s11064-020-03069-0. Epub 2020 Jun 10.
4
Huntington's disease in the United States: Variation by demographic and socioeconomic factors.美国亨廷顿病:人口统计学和社会经济因素的差异。
Mov Disord. 2019 Jun;34(6):858-865. doi: 10.1002/mds.27653. Epub 2019 Mar 13.
5
Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings.干细胞在亨廷顿病啮齿动物模型中的治疗效果:综述和电生理发现。
CNS Neurosci Ther. 2018 Apr;24(4):329-342. doi: 10.1111/cns.12839. Epub 2018 Mar 6.
6
Glycation potentiates neurodegeneration in models of Huntington's disease.糖基化增强亨廷顿病模型中的神经退行性变。
Sci Rep. 2016 Nov 18;6:36798. doi: 10.1038/srep36798.
7
Analysis of the GGGGCC Repeat Expansions of the C9orf72 Gene in SCA3/MJD Patients from China.中国SCA3/MJD患者C9orf72基因GGGGCC重复序列扩增分析。
PLoS One. 2015 Jun 17;10(6):e0130336. doi: 10.1371/journal.pone.0130336. eCollection 2015.
8
Common dysregulation network in the human prefrontal cortex underlies two neurodegenerative diseases.人类前额叶皮层中常见的失调网络是两种神经退行性疾病的基础。
Mol Syst Biol. 2014 Jul 30;10(7):743. doi: 10.15252/msb.20145304.
9
Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes.多种基因中CAG序列对脊髓小脑共济失调发病年龄的调节作用。
Brain. 2014 Sep;137(Pt 9):2444-55. doi: 10.1093/brain/awu174. Epub 2014 Jun 26.
10
Development of an ELISA assay for the quantification of soluble huntingtin in human blood cells.用于定量人血细胞中可溶性亨廷顿蛋白的 ELISA 检测法的开发。
BMC Biochem. 2013 Nov 25;14:34. doi: 10.1186/1471-2091-14-34.
Prog Neuropsychopharmacol Biol Psychiatry. 2003 Apr;27(2):255-65. doi: 10.1016/S0278-5846(03)00021-6.
4
Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice.饮食限制可使亨廷顿蛋白突变小鼠的葡萄糖代谢和脑源性神经营养因子(BDNF)水平正常化,减缓疾病进展,并延长生存期。
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2911-6. doi: 10.1073/pnas.0536856100. Epub 2003 Feb 14.
5
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease.伏立诺他,一种组蛋白去乙酰化酶抑制剂,可改善亨廷顿舞蹈病小鼠模型的运动功能障碍。
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2041-6. doi: 10.1073/pnas.0437870100. Epub 2003 Feb 7.
6
Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.亨廷顿舞蹈症小鼠模型中皮质纹状体通路的短暂性和进行性电生理改变
J Neurosci. 2003 Feb 1;23(3):961-9. doi: 10.1523/JNEUROSCI.23-03-00961.2003.
7
Pyramidal cell loss in motor cortices in Huntington's disease.亨廷顿舞蹈症患者运动皮质中的锥体神经元丢失
Neurobiol Dis. 2002 Aug;10(3):378-86. doi: 10.1006/nbdi.2002.0528.
8
A mouse model of spinal and bulbar muscular atrophy.脊髓延髓肌肉萎缩的小鼠模型。
Hum Mol Genet. 2002 Sep 1;11(18):2103-11. doi: 10.1093/hmg/11.18.2103.
9
Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses.通过微阵列分析检测亨廷顿蛋白诱导的纹状体细胞中的早期转录谱。
Hum Mol Genet. 2002 Aug 15;11(17):1953-65. doi: 10.1093/hmg/11.17.1953.
10
Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease.在亨廷顿舞蹈症小鼠模型中,亨廷顿蛋白长度增加会减少多聚谷氨酰胺诱导的基因表达变化的数量。
Hum Mol Genet. 2002 Aug 15;11(17):1939-51. doi: 10.1093/hmg/11.17.1939.